Skip to content
Dose Brief
Menu
No. 24 on the board · Grade B−

Mochi Health review

A recognizable coaching-forward brand, but availability is capped at roughly 15 states.

Visit Mochi Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$138/mo
Tirzepatide
$238/mo
Coverage
15 states
Brand-name
Compounded only
On the trackerStableprice stable$138 sema / $238 tirz; footprint capped near 15 states.

The scorecard

Mochi Health scored on our six Brief Score factors. See the methodology.

Price Stability83/100
Supply Reliability83/100
Transparency82/100
Access Breadth78/100
Clinical Oversight80/100
Track Record82/100

What we like

  • Well-known consumer brand
  • Both molecules disclosed
  • Coaching-oriented program

The caveats

  • Limited to ~15 states
  • Not LegitScript-certified
  • No oral route

The brief

Best for: Readers in its served states who want a known consumer brand with a coaching bent. A recognizable coaching-forward brand, but availability is capped at roughly 15 states.

Ranked #24 of 25 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 24 other providers we've reviewed, in our overall ranking order.

Pricing, states and verification reflect Mochi Health's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Mochi Health's site. Not medical advice; see our disclosure.

← Back to all rankings